-
1
-
-
84960119237
-
Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer.
-
Bordi, P.; Del Re, M.; Danesi, R.; Tiseo, M. Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer. Transl. Lung Cancer Res. 2015, 4, 584–597.
-
(2015)
Transl. Lung Cancer Res
, vol.4
, pp. 584-597
-
-
Bordi, P.1
Del Re, M.2
Danesi, R.3
Tiseo, M.4
-
2
-
-
84975076514
-
Circulating DNA as a strongmultimarker prognostic tool for metastatic colorectal cancer patient management care.
-
El Messaoudi, S.; Mouliere, F.; Du Manoir, S.; Bascoul-Mollevi, C.; Gillet, B.; Nouaille, M.; Fiess, C.; Crapez, E.; Bibeau, F.; Theillet, C.; et al. Circulating DNA as a strongmultimarker prognostic tool for metastatic colorectal cancer patient management care. Clin. Cancer Res. 2016, 22, 3067–3077.
-
(2016)
Clin. Cancer Res
, vol.22
, pp. 3067-3077
-
-
El Messaoudi, S.1
Mouliere, F.2
Du Manoir, S.3
Bascoul-Mollevi, C.4
Gillet, B.5
Nouaille, M.6
Fiess, C.7
Crapez, E.8
Bibeau, F.9
Theillet, C.10
-
3
-
-
84930448896
-
Colorectal cancer: Using blood samples and tumor tissue to detect K-ras mutations.
-
Li, Y.; Fu, X.-H.; Yuan, J.-Q.; Yang, Z.-Y.; Mao, C.; Dong, X.-M.; Tang, J.-L.; Wang, S.-Y. Colorectal cancer: Using blood samples and tumor tissue to detect K-ras mutations. Expert Rev. Anticancer Ther. 2015, 15, 715–725.
-
(2015)
Expert Rev. Anticancer Ther
, vol.15
, pp. 715-725
-
-
Li, Y.1
Fu, X.-H.2
Yuan, J.-Q.3
Yang, Z.-Y.4
Mao, C.5
Dong, X.-M.6
Tang, J.-L.7
Wang, S.-Y.8
-
4
-
-
84958152148
-
Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification
-
Marcinkowska-Swojak, M.; Handschuh, L.; Wojciechowski, P.; Goralski, M.; Tomaszewski, K.; Kazmierczak, M.; Lewandowski, K.; Komarnicki, M.; Blazewicz, J.; Figlerowicz, M.; et al. Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification. Mutat. Res.-Fundam. Mol. Mech. Mutagen. 2016, 786, 14–26.
-
(2016)
Mutat. Res.-Fundam. Mol. Mech. Mutagen
, vol.786
, pp. 14-26
-
-
Marcinkowska-Swojak, M.1
Handschuh, L.2
Wojciechowski, P.3
Goralski, M.4
Tomaszewski, K.5
Kazmierczak, M.6
Lewandowski, K.7
Komarnicki, M.8
Blazewicz, J.9
Figlerowicz, M.10
-
5
-
-
84898476658
-
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.
-
Thierry, A.R.; Mouliere, F.; El Messaoudi, S.; Mollevi, C.; Lopez-Crapez, E.; Rolet, F.; Gillet, B.; Gongora, C.; Dechelotte, P.; Robert, B.; et al. Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat. Med. 2014, 20, 430–435.
-
(2014)
Nat. Med
, vol.20
, pp. 430-435
-
-
Thierry, A.R.1
Mouliere, F.2
El Messaoudi, S.3
Mollevi, C.4
Lopez-Crapez, E.5
Rolet, F.6
Gillet, B.7
Gongora, C.8
Dechelotte, P.9
Robert, B.10
-
6
-
-
84978062740
-
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
-
Tie, J.; Wang, Y.; Tomasetti, C.; Li, L.; Springer, S.; Kinde, I.; Silliman, N.; Tacey, M.; Wong, H.-L.; Christie, M.; et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci. Transl. Med. 2016, 8, 346ra392.
-
(2016)
Sci. Transl. Med
, vol.8
, pp. 346ra392
-
-
Tie, J.1
Wang, Y.2
Tomasetti, C.3
Li, L.4
Springer, S.5
Kinde, I.6
Silliman, N.7
Tacey, M.8
Wong, H.-L.9
Christie, M.10
-
7
-
-
84892920228
-
Characterizing DNA methylation alterations from The Cancer Genome Atlas
-
Weisenberger, D.J. Characterizing DNA methylation alterations from The Cancer Genome Atlas. J. Clin. Investig. 2014, 124, 17–23.
-
(2014)
J. Clin. Investig
, vol.124
, pp. 17-23
-
-
Weisenberger, D.J.1
-
8
-
-
84923090486
-
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
-
Stirzaker, C.; Zotenko, E.; Song, J.Z.; Qu, W.; Nair, S.S.; Locke, W.J.; Stone, A.; Armstong, N.J.; Robinson, M.D.; Dobrovic, A.; et al. Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value. Nat. Commun. 2015, 6, 5899.
-
(2015)
Nat. Commun
, vol.6
, pp. 5899
-
-
Stirzaker, C.1
Zotenko, E.2
Song, J.Z.3
Qu, W.4
Nair, S.S.5
Locke, W.J.6
Stone, A.7
Armstong, N.J.8
Robinson, M.D.9
Dobrovic, A.10
-
9
-
-
0028152397
-
Cytidine methylation of regulatory sequences near the -class glutathione S-transferase gene accompanies human prostatic carcinogenesis
-
Lee, W.H.; Morton, R.A.; Epstein, J.I.; Brooks, J.D.; Campbell, P.A.; Bova, G.S.; Hsieh, W.S.; Isaacs, W.B.; Nelson, W.G. Cytidine methylation of regulatory sequences near the -class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA 1994, 91, 11733–11737.
-
(1994)
Proc. Natl. Acad. Sci. USA
, vol.91
, pp. 11733-11737
-
-
Lee, W.H.1
Morton, R.A.2
Epstein, J.I.3
Brooks, J.D.4
Campbell, P.A.5
Bova, G.S.6
Hsieh, W.S.7
Isaacs, W.B.8
Nelson, W.G.9
-
10
-
-
0033545329
-
Detailed methylation analysis of the glutathione S-transferase (GSTP1) gene in prostate cancer
-
Millar, D.S.; Ow, K.K.; Paul, C.L.; Russell, P.J.; Molloy, P.L.; Clark, S.J. Detailed methylation analysis of the glutathione S-transferase (GSTP1) gene in prostate cancer. Oncogene 1999, 18, 1313–1324.
-
(1999)
Oncogene
, vol.18
, pp. 1313-1324
-
-
Millar, D.S.1
Ow, K.K.2
Paul, C.L.3
Russell, P.J.4
Molloy, P.L.5
Clark, S.J.6
-
11
-
-
78049345913
-
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates
-
Schmidt, B.; Liebenberg, V.; Dietrich, D.; Schlegel, T.; Kneip, C.; Seegebarth, A.; Flemming, N.; Seemann, S.; Distler, J.; Lewin, J.; et al. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 2010, 10, 600.
-
(2010)
BMC Cancer
, vol.10
, pp. 600
-
-
Schmidt, B.1
Liebenberg, V.2
Dietrich, D.3
Schlegel, T.4
Kneip, C.5
Seegebarth, A.6
Flemming, N.7
Seemann, S.8
Distler, J.9
Lewin, J.10
-
12
-
-
84871735404
-
Circulating methylated septin 9 DNA in plasma is a biomarker for colorectal cancer
-
DeVos, T.; Tetzner, R.; Model, F.; Weiss, G.; Schuster, M.; Distler, J.; Gruetzmann, R.; Pilarsky, C.; Habermann, J.K.; Fleshner, P.; et al. Circulating methylated septin 9 DNA in plasma is a biomarker for colorectal cancer. Gastroenterology 2009, 136, A623.
-
(2009)
Gastroenterology
, vol.136
-
-
Devos, T.1
Tetzner, R.2
Model, F.3
Weiss, G.4
Schuster, M.5
Distler, J.6
Gruetzmann, R.7
Pilarsky, C.8
Habermann, J.K.9
Fleshner, P.10
-
13
-
-
84870326702
-
Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer
-
Lange, C.P.E.; Campan, M.; Hinoue, T.; Schmitz, R.F.; van der Meulen-de Jong, A.E.; Slingerland, H.; Kok, P.J.M.J.; van Dijk, C.M.;Weisenberger, D.J.; Shen, H.; et al. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS ONE 2012, 7, e50266.
-
(2012)
Plos ONE
, pp. 7
-
-
Lange, C.P.E.1
Campan, M.2
Hinoue, T.3
Schmitz, R.F.4
van der Meulen-de Jong, A.E.5
Slingerland, H.6
Kok, P.J.M.J.7
van Dijk, C.M.8
Weisenberger, D.J.9
Shen, H.10
-
14
-
-
67649635452
-
N-Myc downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer
-
Melotte, V.; Lentjes, M.H.F.M.; van den Bosch, S.M.; Hellebrekers, D.M.E.I.; de hoon, J.P.J.; Wouters, K.A.D.; Daenen, K.L.J.; Partouns-Hendriks, I.E.J.M.; Stessels, F.; Louwagie, J.; et al. N-Myc downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer. J. Natl. Cancer Inst. 2009, 101, 916–927.
-
(2009)
J. Natl. Cancer Inst
, vol.101
, pp. 916-927
-
-
Melotte, V.1
Lentjes, M.H.F.M.2
Van Den Bosch, S.M.3
Hellebrekers, D.M.E.I.4
De Hoon, J.P.J.5
Wouters, K.A.D.6
Daenen, K.L.J.7
Partouns-Hendriks, I.E.J.M.8
Stessels, F.9
Louwagie, J.10
-
15
-
-
84893197219
-
A panel of genes methylated with high frequency in colorectal cancer
-
Mitchell, S.M.; Ross, J.P.; Drew, H.R.; Ho, T.; Brown, G.S.; Saunders, N.F.W.; Duesing, K.R.; Buckley, M.J.; Dunne, R.; Beetson, I.; et al. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer 2014, 14, 54.
-
(2014)
BMC Cancer
, vol.14
, pp. 54
-
-
Mitchell, S.M.1
Ross, J.P.2
Drew, H.R.3
Ho, T.4
Brown, G.S.5
Saunders, N.F.W.6
Duesing, K.R.7
Buckley, M.J.8
Dunne, R.9
Beetson, I.10
-
16
-
-
18644383745
-
Frequent RASSF1A tumour suppressor gene promoter methylation inWilms’ tumour and colorectal cancer
-
Wagner, K.J.; Cooper, W.N.; Grundy, R.G.; Caldwell, G.; Jones, C.;Wadey, R.B.; Morton, D.; Schofield, P.N.; Reik, W.; Latif, F.; et al. Frequent RASSF1A tumour suppressor gene promoter methylation inWilms’ tumour and colorectal cancer. Oncogene 2002, 21, 7277–7282.
-
(2002)
Oncogene
, vol.21
, pp. 7277-7282
-
-
Wagner, K.J.1
Cooper, W.N.2
Grundy, R.G.3
Caldwell, G.4
Jones, C.5
Wadey, R.B.6
Morton, D.7
Schofield, P.N.8
Reik, W.9
Latif, F.10
-
17
-
-
84864423461
-
Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients
-
Avraham, A.; Uhlmann, R.; Shperber, A.; Birnbaum, M.; Sandbank, J.; Sella, A.; Sukumar, S.; Evron, E. Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients. Int. J. Cancer 2012, 131, E1166–E1172.
-
(2012)
Int. J. Cancer
, vol.131
, pp. E1166-E1172
-
-
Avraham, A.1
Uhlmann, R.2
Shperber, A.3
Birnbaum, M.4
Sandbank, J.5
Sella, A.6
Sukumar, S.7
Evron, E.8
-
18
-
-
79954469878
-
Cancer epigenetics: Above and beyond.
-
Brait, M.; Sidransky, D. Cancer epigenetics: Above and beyond. Toxicol. Mech. Methods 2011, 21, 275–288.
-
(2011)
Toxicol. Mech. Methods
, vol.21
, pp. 275-288
-
-
Brait, M.1
Sidransky, D.2
-
19
-
-
84908548256
-
Methylated glutathione S-transferase 1 (MGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
-
Mahon, K.L.; Qu, W.; Devaney, J.; Paul, C.; Castillo, L.;Wykes, R.J.; Chatfield, M.D.; Boyer, M.J.; Stockler, M.R.; Marx, G.; et al. Methylated glutathione S-transferase 1 (MGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer. Br. J. Cancer 2014, 111, 1802–1809.
-
(2014)
Br. J. Cancer
, vol.111
, pp. 1802-1809
-
-
Mahon, K.L.1
Qu, W.2
Devaney, J.3
Paul, C.4
Castillo, L.5
Wykes, R.J.6
Chatfield, M.D.7
Boyer, M.J.8
Stockler, M.R.9
Marx, G.10
-
20
-
-
84857159930
-
Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates
-
Dietrich, D.; Kneip, C.; Raji, O.; Lloglou, T.; Seegebarth, A.; Schlegel, T.; Flemming, N.; Rausch, S.; Distler, J.; Fleischhacker, M.; et al. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int. J. Oncol. 2012, 40, 825–832.
-
(2012)
Int. J. Oncol
, vol.40
, pp. 825-832
-
-
Dietrich, D.1
Kneip, C.2
Raji, O.3
Lloglou, T.4
Seegebarth, A.5
Schlegel, T.6
Flemming, N.7
Rausch, S.8
Distler, J.9
Fleischhacker, M.10
-
21
-
-
84940467390
-
Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer
-
Fantony, J.J.; Abern, M.R.; Gopalakrishna, A.; Owusu, R.; Jack Tay, K.; Lance, R.S.; Inman, B.A. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. Urol. Oncol. 2015, 33, 387.e1–387.e6.
-
(2015)
Urol. Oncol
, vol.33
, pp. e1-e387
-
-
Fantony, J.J.1
Abern, M.R.2
Gopalakrishna, A.3
Owusu, R.4
Jack Tay, K.5
Lance, R.S.6
Inman, B.A.7
-
22
-
-
84961627545
-
Analysing the mutational status of adenomatous polyposis coli (APC) gene in breast cancer
-
Chang, Y.S.; Lin, C.Y.; Yang, S.F.; Ho, C.M.; Chang, J.G. Analysing the mutational status of adenomatous polyposis coli (APC) gene in breast cancer. Cancer Cell Int. 2016, 16, 23.
-
(2016)
Cancer Cell Int
, vol.16
, pp. 23
-
-
Chang, Y.S.1
Lin, C.Y.2
Yang, S.F.3
Ho, C.M.4
Chang, J.G.5
-
23
-
-
84943375035
-
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
-
Sun, K.; Jiang, P.; Chan, K.C.; Wong, J.; Cheng, Y.K.; Liang, R.H.; Chan, W.K.; Ma, E.S.; Chan, S.L.; Cheng, S.H.; et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl. Acad. Sci. USA 2015, 112, E5503–E5512.
-
(2015)
Proc. Natl. Acad. Sci. USA
, vol.112
, pp. E5503-E5512
-
-
Sun, K.1
Jiang, P.2
Chan, K.C.3
Wong, J.4
Cheng, Y.K.5
Liang, R.H.6
Chan, W.K.7
Ma, E.S.8
Chan, S.L.9
Cheng, S.H.10
-
24
-
-
84962407100
-
Identification of tissue-specific cell death using methylation patterns of circulating DNA
-
Lehmann-Werman, R.; Neiman, D.; Zemmour, H.; Moss, J.; Magenheim, J.; Vaknin-Dembinsky, A.; Rubertsson, S.; Nellgård, B.; Blennow, K.; Zetterberg, H.; et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl. Acad. Sci. USA 2016, 113, E1826–E1834.
-
(2016)
Proc. Natl. Acad. Sci. USA
, vol.113
, pp. E1826-E1834
-
-
Lehmann-Werman, R.1
Neiman, D.2
Zemmour, H.3
Moss, J.4
Magenheim, J.5
Vaknin-Dembinsky, A.6
Rubertsson, S.7
Nellgård, B.8
Blennow, K.9
Zetterberg, H.10
-
25
-
-
84954306330
-
Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin
-
Snyder, M.W.; Kircher, M.; Hill, A.J.; Daza, R.M.; Shendure, J. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 2016, 164, 57–68.
-
(2016)
Cell
, vol.164
, pp. 57-68
-
-
Snyder, M.W.1
Kircher, M.2
Hill, A.J.3
Daza, R.M.4
Shendure, J.5
-
26
-
-
84876139704
-
Clinical applications of DNA methylation biomarkers in colorectal cancer
-
Lange, C.P.E.; Laird, P.W. Clinical applications of DNA methylation biomarkers in colorectal cancer. Epigenomics 2013, 5, 105–108.
-
(2013)
Epigenomics
, vol.5
, pp. 105-108
-
-
Lange, C.P.E.1
Laird, P.W.2
-
27
-
-
84867184362
-
Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes
-
Kristensen, L.S.; Raynor, M.P.; Candiloro, I.; Dobrovic, A. Methylation profiling of normal individuals reveals mosaic promoter methylation of cancer-associated genes. Oncotarget 2012, 3, 450–461.
-
(2012)
Oncotarget
, vol.3
, pp. 450-461
-
-
Kristensen, L.S.1
Raynor, M.P.2
Candiloro, I.3
Dobrovic, A.4
-
28
-
-
84943584781
-
A two-gene blood test for methylated DNA sensitive for colorectal cancer
-
Pedersen, S.K.; Baker, R.T.; McEvoy, A.; Murray, D.H.; Thomas, M.; Molloy, P.L.; Mitchell, S.; Lockett, T.; Young, G.P.; LaPointe, L.C. A two-gene blood test for methylated DNA sensitive for colorectal cancer. PLoS ONE 2015, 10, e0125041.
-
(2015)
Plos ONE
, vol.10
-
-
Pedersen, S.K.1
Baker, R.T.2
McEvoy, A.3
Murray, D.H.4
Thomas, M.5
Molloy, P.L.6
Mitchell, S.7
Lockett, T.8
Young, G.P.9
Lapointe, L.C.10
-
29
-
-
85043629408
-
A blood test for methylated BCAT1 and IKZF1 vs. A fecal immunochemical test for detection of colorectal neoplasia. Clin
-
Symonds, E.L.; Pedersen, S.K.; Baker, R.T.; Murray, D.H.; Gaur, S.; Cole, S.R.; Gopalsamy, G.; Mangira, D.; LaPointe, L.C.; Young, G.P. A blood test for methylated BCAT1 and IKZF1 vs. a fecal immunochemical test for detection of colorectal neoplasia. Clin. Transl. Gastroenterol. 2016, 7, e137.
-
(2016)
Transl. Gastroenterol
, vol.7
-
-
Symonds, E.L.1
Pedersen, S.K.2
Baker, R.T.3
Murray, D.H.4
Gaur, S.5
Cole, S.R.6
Gopalsamy, G.7
Mangira, D.8
Lapointe, L.C.9
Young, G.P.10
-
30
-
-
84943586272
-
Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia
-
Pedersen, S.K.; Symonds, E.L.; Baker, R.T.; Murray, D.H.; McEvoy, A.; Van Doorn, S.C.; Mundt, M.W.; Cole, S.R.; Gopalsamy, G.; Mangira, D.; et al. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer 2015, 15, 654.
-
(2015)
BMC Cancer
, vol.15
, pp. 654
-
-
Pedersen, S.K.1
Symonds, E.L.2
Baker, R.T.3
Murray, D.H.4
McEvoy, A.5
Van Doorn, S.C.6
Mundt, M.W.7
Cole, S.R.8
Gopalsamy, G.9
Mangira, D.10
-
31
-
-
64249099411
-
-
7th ed.; Springer: New York, NY, USA
-
Edge, S.B.; Byrd, D.R.; Compton, C.C.; Fritz, A.G.; Greene, F.L.; Trotti, A. AJCC Cancer Staging Manual, 7th ed.; Springer: New York, NY, USA, 2010.
-
(2010)
AJCC Cancer Staging Manual
-
-
Edge, S.B.1
Byrd, D.R.2
Compton, C.C.3
Fritz, A.G.4
Greene, F.L.5
Trotti, A.6
-
32
-
-
84933278041
-
Whole-genome fingerprint of the DNA methylome during human B cell differentiation.
-
Kulis, M.; Merkel, A.; Heath, S.; Queirós, A.C.; Schuyler, R.P.; Castellano, G.; Beekman, R.; Raineri, E.; Esteve, A.; Clot, G.; et al. Whole-genome fingerprint of the DNA methylome during human B cell differentiation. Nat. Genet. 2015, 47, 746–756.
-
(2015)
Nat. Genet
, vol.47
, pp. 746-756
-
-
Kulis, M.1
Merkel, A.2
Heath, S.3
Queirós, A.C.4
Schuyler, R.P.5
Castellano, G.6
Beekman, R.7
Raineri, E.8
Esteve, A.9
Clot, G.10
-
33
-
-
84959519942
-
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.
-
Oakes, C.C.; Seifert, M.; Assenov, Y.; Gu, L.; Przekopowitz, M.; Ruppert, A.; Wang, Q.; Imbusch, C.D.; Serva, A.; Koser, S.D.; et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat. Genet. 2016, 48, 253–264.
-
(2016)
Nat. Genet
, vol.48
, pp. 253-264
-
-
Oakes, C.C.1
Seifert, M.2
Assenov, Y.3
Gu, L.4
Przekopowitz, M.5
Ruppert, A.6
Wang, Q.7
Imbusch, C.D.8
Serva, A.9
Koser, S.D.10
-
34
-
-
84938495948
-
Human body epigenome maps reveal noncanonical DNA methylation variation
-
Schultz, M.D.; He, Y.; Whitaker, J.W.; Hariharan, M.; Mukamel, E.A.; Leung, D.; Rajagopal, N.; Nery, J.N.; Urich, M.A.; Chen, H.; et al. Human body epigenome maps reveal noncanonical DNA methylation variation. Nature 2015, 523, 212–216.
-
(2015)
Nature
, vol.523
, pp. 212-216
-
-
Schultz, M.D.1
He, Y.2
Whitaker, J.W.3
Hariharan, M.4
Mukamel, E.A.5
Leung, D.6
Rajagopal, N.7
Nery, J.N.8
Urich, M.A.9
Chen, H.10
-
35
-
-
84985905521
-
Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma.
-
Kristensen, L.S.; Hansen, J.W.; Kristensen, S.S.; Tholstrup, D.; Harsløf, L.B.; Pedersen, O.B.; De Nully Brown, P.; Grønbæk, K. Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma. Clin. Epigenet. 2016, 8, 95.
-
(2016)
Clin. Epigenet
, vol.8
, pp. 95
-
-
Kristensen, L.S.1
Hansen, J.W.2
Kristensen, S.S.3
Tholstrup, D.4
Harsløf, L.B.5
Pedersen, O.B.6
De Nully Brown, P.7
Grønbæk, K.8
-
36
-
-
84879289642
-
Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer
-
Oh, T.; Kim, N.; Moon, Y.; Kim, M.S.; Hoehn, B.D.; Park, C.H.; Kim, T.S.; Kim, N.K.; Chung, H.C.; An, S. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J. Mol. Diagn. 2013, 15, 498–507.
-
(2013)
J. Mol. Diagn
, vol.15
, pp. 498-507
-
-
Oh, T.1
Kim, N.2
Moon, Y.3
Kim, M.S.4
Hoehn, B.D.5
Park, C.H.6
Kim, T.S.7
Kim, N.K.8
Chung, H.C.9
An, S.10
-
37
-
-
84955586892
-
Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review
-
Xue, M.; Lai, S.C.; Xu, Z.P.; Wang, L.J. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review. J. Dig. Dis. 2015, 16, 699–712.
-
(2015)
J. Dig. Dis
, vol.16
, pp. 699-712
-
-
Xue, M.1
Lai, S.C.2
Xu, Z.P.3
Wang, L.J.4
|